Related Experiment Videos
Bacterial genomics as a potential tool for discovering new antimicrobial agents
1Division of Human Immunology, Hanson Center for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia. scott.waterman@imvs.sa.gov.au
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|June 27, 2002
Summary
Emerging infectious diseases and antimicrobial resistance pose a growing threat. New drug targets are urgently needed, with advances in genomics and computational tools offering promising avenues for developing novel antimicrobial agents.
Area of Science:
- Microbiology
- Genomics
- Drug Discovery
Background:
- The last 30 years have seen a rise in new and re-emerging infectious diseases.
- Microbial drug resistance is rendering current antimicrobial agents ineffective.
- There is a critical need for novel antimicrobial agents and drug targets.
Purpose of the Study:
- To highlight the urgent need for new antimicrobial agents and drug targets.
- To discuss the role of advancements in genomics and computational tools in identifying novel targets.
- To explore the application and limitations of these new approaches in combating antimicrobial resistance.
Main Methods:
- High-throughput automated DNA sequencing to generate whole genome sequences of microbial pathogens.
- Development of genetic tools for selecting genes of interest.
- Computational advances for testing candidate drugs and identifying potential targets.
Main Results:
- Genomic sequencing has provided extensive genetic information on microbial pathogens.
- New genetic and computational tools enable the selection and testing of potential drug targets.
- While no new drugs have been developed yet, these approaches show promise.
Conclusions:
- Genomic and computational advancements are crucial for identifying novel antimicrobial drug targets.
- Further research is needed to overcome the limitations of these new approaches.
- These strategies are vital for addressing the escalating problem of antimicrobial drug resistance.